Broadly Protective Strategies Against Influenza Viruses: Universal Vaccines and Therapeutics
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Broadly Protective Strategies Against Influenza Viruses: Universal Vaccines and Therapeutics
Authors
Keywords
-
Journal
Frontiers in Microbiology
Volume 11, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-02-07
DOI
10.3389/fmicb.2020.00135
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Enhancing the cross protective efficacy of live attenuated influenza virus vaccine by supplemented vaccination with M2 ectodomain virus-like particles
- (2019) Young-Tae Lee et al. VIROLOGY
- New Vaccine Design and Delivery Technologies
- (2019) Masaru Kanekiyo et al. JOURNAL OF INFECTIOUS DISEASES
- Preventing an Antigenically Disruptive Mutation in Egg-Based H3N2 Seasonal Influenza Vaccines by Mutational Incompatibility
- (2019) Nicholas C. Wu et al. Cell Host & Microbe
- Development of Influenza B Universal Vaccine Candidates Using the “Mosaic” Hemagglutinin Approach
- (2019) Weina Sun et al. JOURNAL OF VIROLOGY
- Pre-existing anti-neuraminidase antibodies are associated with shortened duration of influenza A (H1N1)pdm virus shedding and illness in naturally infected adults
- (2019) Hannah E Maier et al. CLINICAL INFECTIOUS DISEASES
- Influenza M2 virus-like particle vaccination enhances protection in combination with avian influenza HA VLPs
- (2019) Hae-Ji Kang et al. PLoS One
- Sequential Immunization With Live-Attenuated Chimeric Hemagglutinin-Based Vaccines Confers Heterosubtypic Immunity Against Influenza A Viruses in a Preclinical Ferret Model
- (2019) Wen-Chun Liu et al. Frontiers in Immunology
- Cell-Based Quadrivalent Inactivated Influenza Virus Vaccine (Flucelvax® Tetra/Flucelvax Quadrivalent®): A Review in the Prevention of Influenza
- (2019) Yvette N. Lamb DRUGS
- Extending the Stalk Enhances Immunogenicity of the Influenza Virus Neuraminidase
- (2019) Felix Broecker et al. JOURNAL OF VIROLOGY
- Neuraminidase expressing virus-like particle vaccine provides effective cross protection against influenza virus
- (2019) Ki-Hye Kim et al. VIROLOGY
- Immunogenicity of chimeric haemagglutinin-based, universal influenza virus vaccine candidates: interim results of a randomised, placebo-controlled, phase 1 clinical trial
- (2019) David I Bernstein et al. LANCET INFECTIOUS DISEASES
- A Universal Influenza Vaccine: The Strategic Plan for the National Institute of Allergy and Infectious Diseases
- (2018) Emily J Erbelding et al. JOURNAL OF INFECTIOUS DISEASES
- From Original Antigenic Sin to the Universal Influenza Virus Vaccine
- (2018) Carole Henry et al. TRENDS IN IMMUNOLOGY
- Economic burden of seasonal influenza in the United States
- (2018) Wayan C.W.S. Putri et al. VACCINE
- Protection by universal influenza vaccine is mediated by memory CD4 T cells
- (2018) Sophie A. Valkenburg et al. VACCINE
- Immunogenicity and Protection Against Influenza H7N3 in Mice by Modified Vaccinia Virus Ankara Vectors Expressing Influenza Virus Hemagglutinin or Neuraminidase
- (2018) Clement A. Meseda et al. Scientific Reports
- Update: ACIP Recommendations for the Use of Quadrivalent Live Attenuated Influenza Vaccine (LAIV4) — United States, 2018–19 Influenza Season
- (2018) Lisa A. Grohskopf et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Cell culture-derived influenza vaccines in the severe 2017–2018 epidemic season: a step towards improved influenza vaccine effectiveness
- (2018) Ian G. Barr et al. npj Vaccines
- Correction: Split inactivated COBRA vaccine elicits protective antibodies against H1N1 and H3N2 influenza viruses
- (2018) James D. Allen et al. PLoS One
- Broadened immunity against influenza by vaccination with computationally designed influenza virus N1 neuraminidase constructs
- (2018) E. R. Job et al. npj Vaccines
- Computationally Optimized Broadly Reactive Hemagglutinin Elicits Hemagglutination Inhibition Antibodies against a Panel of H3N2 Influenza Virus Cocirculating Variants
- (2017) Terianne M. Wong et al. JOURNAL OF VIROLOGY
- Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains
- (2017) Seth J. Zost et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A structural explanation for the low effectiveness of the seasonal influenza H3N2 vaccine
- (2017) Nicholas C. Wu et al. PLoS Pathogens
- A universal influenza virus vaccine candidate confers protection against pandemic H1N1 infection in preclinical ferret studies
- (2017) Raffael Nachbagauer et al. npj Vaccines
- The Hemagglutinin Stem-Binding Monoclonal Antibody VIS410 Controls Influenza Virus-Induced Acute Respiratory Distress Syndrome
- (2016) Tatiana Baranovich et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Vaccine-Induced Antibodies that Neutralize Group 1 and Group 2 Influenza A Viruses
- (2016) M. Gordon Joyce et al. CELL
- Structure and Function Analysis of an Antibody Recognizing All Influenza A Subtypes
- (2016) Nicole L. Kallewaard et al. CELL
- Letter to the editor: Potential causes of the decreased effectiveness of the influenza A(H1N1)pdm09 strain in live attenuated influenza vaccines
- (2016) Christopher S Ambrose et al. Eurosurveillance
- Fluzone® High-Dose Influenza Vaccine
- (2016) Corwin A. Robertson et al. Expert Review of Vaccines
- Design and Characterization of a Computationally Optimized Broadly Reactive Hemagglutinin Vaccine for H1N1 Influenza Viruses
- (2016) Donald M. Carter et al. JOURNAL OF VIROLOGY
- Epitope specificity plays a critical role in regulating antibody-dependent cell-mediated cytotoxicity against influenza A virus
- (2016) Wenqian He et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Evaluation of Antihemagglutinin and Antineuraminidase Antibodies as Correlates of Protection in an Influenza A/H1N1 Virus Healthy Human Challenge Model
- (2016) Matthew J. Memoli et al. mBio
- Antibody to Influenza Virus Neuraminidase: An Independent Correlate of Protection
- (2015) Arnold S. Monto et al. JOURNAL OF INFECTIOUS DISEASES
- Cross-Reactive Neuraminidase-Inhibiting Antibodies Elicited by Immunization with Recombinant Neuraminidase Proteins of H5N1 and Pandemic H1N1 Influenza A Viruses
- (2015) Wen-Chun Liu et al. JOURNAL OF VIROLOGY
- Hemagglutinin-stem nanoparticles generate heterosubtypic influenza protection
- (2015) Hadi M Yassine et al. NATURE MEDICINE
- A broadly neutralizing human monoclonal antibody is effective against H7N9
- (2015) Kannan Tharakaraman et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A stable trimeric influenza hemagglutinin stem as a broadly protective immunogen
- (2015) A. Impagliazzo et al. SCIENCE
- Strengthening the influenza vaccine virus selection and development process
- (2015) William K. Ampofo et al. VACCINE
- Efficacy and Safety of Treatment With an Anti-M2e Monoclonal Antibody in Experimental Human Influenza
- (2014) Eleanor L. Ramos et al. JOURNAL OF INFECTIOUS DISEASES
- Broadly neutralizing hemagglutinin stalk–specific antibodies require FcγR interactions for protection against influenza virus in vivo
- (2014) David J DiLillo et al. NATURE MEDICINE
- Low 2012–13 Influenza Vaccine Effectiveness Associated with Mutation in the Egg-Adapted H3N2 Vaccine Strain Not Antigenic Drift in Circulating Viruses
- (2014) Danuta M. Skowronski et al. PLoS One
- IL-15 adjuvanted multivalent vaccinia-based universal influenza vaccine requires CD4+ T cells for heterosubtypic protection
- (2014) S. A. Valkenburg et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- An In Vivo Human-Plasmablast Enrichment Technique Allows Rapid Identification of Therapeutic Influenza A Antibodies
- (2013) Gerald Nakamura et al. Cell Host & Microbe
- Hemagglutinin Stalk-Based Universal Vaccine Constructs Protect against Group 2 Influenza A Viruses
- (2013) I. Margine et al. JOURNAL OF VIROLOGY
- Chimeric Hemagglutinin Influenza Virus Vaccine Constructs Elicit Broadly Protective Stalk-Specific Antibodies
- (2013) F. Krammer et al. JOURNAL OF VIROLOGY
- Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies
- (2013) Masaru Kanekiyo et al. NATURE
- Cellular immune correlates of protection against symptomatic pandemic influenza
- (2013) Saranya Sridhar et al. NATURE MEDICINE
- A novel, disruptive vaccination technology
- (2013) Karl-Josef Kallen et al. Human Vaccines & Immunotherapeutics
- Intranasal vaccination with an inactivated whole influenza virus vaccine induces strong antibody responses in serum and nasal mucus of healthy adults
- (2013) Akira Ainai et al. Human Vaccines & Immunotherapeutics
- Preliminary Assessment of the Efficacy of a T-Cell–Based Influenza Vaccine, MVA-NP+M1, in Humans
- (2012) Patrick J. Lillie et al. CLINICAL INFECTIOUS DISEASES
- Safety and Immunogenicity of Multimeric-001—a Novel Universal Influenza Vaccine
- (2012) Jacob Atsmon et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Memory CD4+ T cells protect against influenza through multiple synergizing mechanisms
- (2012) K. Kai McKinstry et al. JOURNAL OF CLINICAL INVESTIGATION
- Multiple Redundant Effector Mechanisms of CD8+ T Cells Protect against Influenza Infection
- (2012) H. Hamada et al. JOURNAL OF IMMUNOLOGY
- A Computationally Optimized Hemagglutinin Virus-Like Particle Vaccine Elicits Broadly Reactive Antibodies that Protect Nonhuman Primates from H5N1 Infection
- (2012) Brendan M. Giles et al. JOURNAL OF INFECTIOUS DISEASES
- Influenza Viruses Expressing Chimeric Hemagglutinins: Globular Head and Stalk Domains Derived from Different Subtypes
- (2012) R. Hai et al. JOURNAL OF VIROLOGY
- Virus-like Particles Containing Multiple M2 Extracellular Domains Confer Improved Cross-protection Against Various Subtypes of Influenza Virus
- (2012) Min-Chul Kim et al. MOLECULAR THERAPY
- Protective efficacy of in vitro synthesized, specific mRNA vaccines against influenza A virus infection
- (2012) Benjamin Petsch et al. NATURE BIOTECHNOLOGY
- Hemagglutinin stalk antibodies elicited by the 2009 pandemic influenza virus as a mechanism for the extinction of seasonal H1N1 viruses
- (2012) N. Pica et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Highly Conserved Protective Epitopes on Influenza B Viruses
- (2012) C. Dreyfus et al. SCIENCE
- Protection against a lethal H5N1 influenza challenge by intranasal immunization with virus-like particles containing 2009 pandemic H1N1 neuraminidase in mice
- (2012) Judith D. Easterbrook et al. VIROLOGY
- Live and Inactivated Influenza Vaccines Induce Similar Humoral Responses, but Only Live Vaccines Induce Diverse T-Cell Responses in Young Children
- (2011) Daniel F. Hoft et al. JOURNAL OF INFECTIOUS DISEASES
- DNA priming and influenza vaccine immunogenicity: two phase 1 open label randomised clinical trials
- (2011) Julie E Ledgerwood et al. LANCET INFECTIOUS DISEASES
- A Neutralizing Antibody Selected from Plasma Cells That Binds to Group 1 and Group 2 Influenza A Hemagglutinins
- (2011) D. Corti et al. SCIENCE
- A computationally optimized broadly reactive antigen (COBRA) based H5N1 VLP vaccine elicits broadly reactive antibodies in mice and ferrets
- (2011) Brendan M. Giles et al. VACCINE
- Potent CD8+ T-Cell Immunogenicity in Humans of a Novel Heterosubtypic Influenza A Vaccine, MVA-NP+M1
- (2010) T. K. Berthoud et al. CLINICAL INFECTIOUS DISEASES
- Universal Vaccine Based on Ectodomain of Matrix Protein 2 of Influenza A: Fc Receptors and Alveolar Macrophages Mediate Protection
- (2010) K. El Bakkouri et al. JOURNAL OF IMMUNOLOGY
- Human antibodies reveal a protective epitope that is highly conserved among human and nonhuman influenza A viruses
- (2010) Andres G. Grandea et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Influenza Virus Vaccine Based on the Conserved Hemagglutinin Stalk Domain
- (2010) J. Steel et al. mBio
- FluBlok, a next generation influenza vaccine manufactured in insect cells
- (2009) Manon M.J. Cox et al. BIOLOGICALS
- Vaccinia Virus-Based Multivalent H5N1 Avian Influenza Vaccines Adjuvanted with IL-15 Confer Sterile Cross-Clade Protection in Mice
- (2009) L. L. M. Poon et al. JOURNAL OF IMMUNOLOGY
- Tc17, a Unique Subset of CD8 T Cells That Can Protect against Lethal Influenza Challenge
- (2009) H. Hamada et al. JOURNAL OF IMMUNOLOGY
- Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses
- (2009) Jianhua Sui et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Antibody Recognition of a Highly Conserved Influenza Virus Epitope
- (2009) D. C. Ekiert et al. SCIENCE
- Heterosubtypic Neutralizing Monoclonal Antibodies Cross-Protective against H5N1 and H1N1 Recovered from Human IgM+ Memory B Cells
- (2008) Mark Throsby et al. PLoS One
- Complement and natural antibody are required in the long-term memory response to influenza virus
- (2008) Santiago Fernandez Gonzalez et al. VACCINE
- Development of a universal influenza A vaccine based on the M2e peptide fused to the papaya mosaic virus (PapMV) vaccine platform
- (2008) Jérôme Denis et al. VACCINE
- Efficient induction of mucosal and systemic immune responses by virus-like particles administered intranasally: implications for vaccine design
- (2007) Juliana Bessa et al. EUROPEAN JOURNAL OF IMMUNOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started